Effects of clozapine, olanzapine and haloperidol on ethanol-induced ascorbic acid release in mouse striatum

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 1, 2005, Pages 83-89

  Hou, Yue ^a   Yang, Jing Yu ^a   Wu, Chun Fu ^a   Huang, Mei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ascorbic acid; Clozapine; Ethanol; Haloperidol; Microdialysis; Olanzapine

Indexed keywords

ALCOHOL; ASCORBIC ACID; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; ELECTROCHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; MOUSE; NONHUMAN;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIPSYCHOTIC AGENTS; ASCORBIC ACID; BENZODIAZEPINES; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CLOZAPINE; DIALYSIS; ETHANOL; HALOPERIDOL; MALE; MICE; NEOSTRIATUM; SEROTONIN AGONISTS;

EID: 10944269376     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.10.009     Document Type: Article

References (49)

1. V.P. Bakshi, and M.A. Geyer Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine Psychopharmacology 122 1995 198 201
2. V.P. Bakshi, N.R. Swerdlow, and M.A. Geyer Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response J. Pharmacol. Exp. Ther. 271 1994 787 794
3. N. Bhana, R.H. Foster, R. Olney, and G.L. Plosker Olanzapine: an updated review of its use in the management of schizophrenia Drugs 61 2001 111 161
4. C. Bolden, B. Cusack, and E. Richelson Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells J. Pharmacol. Exp. Ther. 260 1992 576 580
5. D.W. Bradford, M.H. Chakos, B.B. Sheitman, and J.A. Lieberman Atypical antipsychotic drugs in treatment-refractory schizophrenia Psychiatr. Ann. 28 1998 618
6. M.P. Brazell, S.N. Mitchell, M.H. Joseph, and J.A. Gray Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen Neuropharmacology 29 1990 1177 1185
7. 1-adrenergic receptors in vitro Schizophr. Res. 37 1999 107 122
8. F. Bymaster, K.W. Perry, D.L. Nelson, D.T. Wong, K. Rasmussen, N.A. Moore, and D.O. Calligaro Olanzapine: a basic science update Br. J. Psychiatry 174 Suppl. 37 1999 S36 S40
9. R. Corbett, H. Hartman, L.L. Kerman, A.T. Woods, J.T. Strupczewski, G.C. Helsley, P.C. Conway, and R.W. Dunn Effects of atypical antipsychotic agents on social behavior in rodents Pharmacol. Biochem. Behav. 45 1993 9 17
10. R. Corbett, F. Camacho, A.T. Woods, L.L. Kerman, R.J. Fishkin, K. Brooks, and R.W. Dunn Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors Psychopharmacology 120 1995 67 74
11. F. Crespi, and P.E. Keane The effect of diazepam and RO15-1788 on extracellular ascorbic acid, DOPAC and 5-HIAA in striatum of anesthetized and conscious freely moving rats, as measured by differential pulse voltammetry Neurosci. Res. 4 1987 323 341
12. K.L. Davis, R.S. Kahn, G. Ko, and M. Davidson Dopamine in schizophrenia: a review and reconceptualization Am. J. Psychiatry 148 1991 1474 1486
13. 2-like' agonist RU 24213 Psychopharmacology 124 1996 40 49
14. G.E. Duncan, S. Miyamoto, J.N. Leipzig, and J.A. Lieberman Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism J. Pharmacol. Exp. Ther. 293 2000 8 14
15. P. Enrico, G. Esposito, M.A. Mura, L. Fresu, G. De Natale, E. Miele, M.S. Desolo, and M. Miele Effect of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats Brain Res. 745 1997 173 182
16. A receptors Eur. J. Pharmacol. 349 1998 R7 R8
17. Y. Fu, Z.T. Zhu, L.J. Chen, L.P. Yu, and G.Z. Jin Behavioral characteristics of olanzapine: an atypical neuroleptic Acta Pharmacol. Sin. 21 2000 329 334
18. 2 receptors Int. Clin. Psychopharmacol. 10 1995 19 30
19. I. Kandish, and T. Van Groen Differences in lesion-induced hippocampal plasticity between mice and rats Neuroscience 116 2003 499 509
20. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia Am. J. Psychiatry 156 1999 286 293
21. B.J. Kinon, and J.A. Lieberman Mechanisms of action of atypical antipsychotic drugs: a critical analysis Psychopharmacology 124 1996 2 34
22. X.M. Li, K.W. Perry, D.T. Wong, and F.P. Bymaster Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum Psychopharmacology 136 1998 153 161
23. J. Liu, C.F. Wu, W. Liu, H.L. Zhang, and C.L. Li Involvement of corticostriatal glutamatergic pathway in regulation of ethanol-induced ascorbic acid release in rat striatum Addict. Biol. 4 1999 272 282
24. W. Liu, C.F. Wu, M. Huang, and K. Xiao Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats Brain Res. 869 2000 31 38
25. W. Liu, C.F. Wu, J. Liu, M. Huang, and K. Xiao Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum Eur. J. Pharmacol. 398 2000 333 339
26. N.A. Moore, N.C. Tye, M.S. Axton, and F.C. Risius The behavioral pharmacology of olanzapine, a novel atypical agent J. Pharmacol. Exp. Ther. 262 1992 545 551
27. 2 receptors Psychopharmacology (Berl) 138 1998 215 216
28. I. Ninan, K.E. Jardemark, and R.Y. Wang Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-d-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex Neuropharmacology 44 2003 462 472
29. R.L. Nunes-de-Souza, A. Canto-de-Souza, M. da-Costa, R.V. Fornari, F.G. Graeff, and I.R. Pela Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam Psychopharmacology 150 2000 300 310
30. G.S. Robertson, and H.C. Fibiger Effects of olanzapine on regional C-Fos expression in rat forebrain Neuropsychopharmacology 14 1996 105 110
31. 1A receptor activation Eur. J. Pharmacol. 338 1997 R3 R5
32. B.L. Roth, S.C. Craigo, M.S. Choudhary, A. Uluer, F.J. Monsma, Y. Shen, H.Y. Meltzer, and D.R. Sibley Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors J. Pharmacol. Exp. Ther. 268 1994 1403 1410
33. 1 receptor agonist Eur. J. Pharmacol. 307 1996 27 31
34. F. Sams-Dodd Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test Behav. Pharmacol. 8 1997 196 215
35. V. Sanchez, J. Camarero, E. O'Shea, A.R. Green, and M.I. Colado Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats Neuropharmacology 44 2003 449 461
36. R.M. Saponjic, K. Mueller, D. Krug, and P.M. Kunko The effects of haloperidol, scopolamine, and MK-801 on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo Pharmacol. Biochem. Behav. 48 1994 161 168
37. A. Schotte, P.F. Janssen, W. Gommeren, W.H. Luyten, P. Van Gompel, A.S. Lesage, K. De Loore, and J.E. Leysen Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology 124 1996 57 73
38. R.G.W. Staal, K.A. Hogan, C.L. Liang, D.C. German, and P.K. Sonsalla In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium J. Pharmacol. Exp. Ther. 293 2000 329 335
39. C.M. Stephenson, and L.S. Pilowsky Psychological of olanzapine. A review Br. J. Psychiatry 174 Suppl. 38 1999 S52 S58
40. N.R. Swerdlow, V.P. Bakshi, and M.A. Geyer Seroquel restores sensorimotor gating in phencyclidine-treated rats J. Pharmacol. Exp. Ther. 279 1996 1290 1299
41. 2A receptor antagonist and putative antipsychotic, block dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats Neuropsychopharmacology 20 1999 311 321
42. C.F. Wu, R. Bertorelli, M. Sacconi, G. Pepeu, and S. Consolo Decrease of brain acetylcholine release in aging freely moving rats detected by microdialysis Neurobiol. Aging 9 1988 357 361
43. 1A receptors mediate inhibition of ethanol-induced ascorbic acid release in rat striatum studied by microdialysis Neurosci. Lett. 250 1998 95 98
44. C.F. Wu, W. Liu, J. Liu, and C.H. Yeh dl-Fenfluramine inhibits ethanol-induced ascorbic acid release in rat striatum studied by microdialysis Addict. Biol. 3 1998 295 308
45. 3 receptors in regulation of ethanol-induced ascorbic acid release in rat striatum Addict. Biol. 6 2001 25 34
46. P.G. Yan, C.F. Wu, M. Huang, and W. Liu Role of nitric oxide in ethanol-induced ascorbic acid release in striatum of freely moving mice Toxicol. Lett. 145 2003 69 78
47. X.P. Zeng, F. Le, and E. Richelson Muscarinic m4 receptor activation by some atypical antipsychotic drugs Eur. J. Pharmacol. 321 1997 349 354
48. T. Zetterstrom, T. Sharp, C.A. Marsden, and U. Ungerstedt In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine J. Neurochem. 41 1983 1769 1773
49. 4 receptor agonist Eur. J. Pharmacol. 269 1994 R1 R2